Atossa Therapeutics, Inc. (ATOS)
4.92
-0.05
(-1.01%)
USD |
NASDAQ |
May 22, 15:50
Atossa Therapeutics EPS Diluted (Quarterly) : -1.112 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.182 |
| Plus Therapeutics, Inc. | -1.045 |
| Perspective Therapeutics, Inc. | -0.2528 |
| Myriad Genetics, Inc. | -0.3639 |
| AVITA Medical, Inc. | -0.3474 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.589M |
| Total Expenses (Quarterly) | 9.589M |
| Enterprise Value | 10.97M |
| Earnings Yield | -88.82% |
| Normalized Earnings Yield | -88.82 |